Cardiac Insight, a young company with spin-out technology from the University of Washington, scored FDA 510(k) clearance for its tiny atrial fibrillation monitoring device called Stealth.
The Bellevue, Wash.-based company was incorporated in 2008 and developed Stealth Ambulatory Monitor for less than $2 million, according to reporting by Xconomy.